Mankind Pharma

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

Nuvama buy recommendations, Nuvama top stock picks

Jefferies’ September shopping list: M&M, Sun Pharma & 3 more stocks set to rally – Do you own them?

Jefferies names M&M, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma as top September buys—see why these stocks could…

September 15, 2025 11:15 IST

From Adani Enterprises, Maruti Suzuki, Coal India to Dabur India – Here are 10 stocks to watch

Stocks to watch today, August 01: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…

August 1, 2025 06:46 IST

Trump tariff on India, pharma sector impact, Indian pharma exports

Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting

Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…

July 31, 2025 10:59 IST

midday stock movers, MRF share price, PN Gadgil Jewellers Q1 results

Stocks making the biggest moves midday: HCL Tech, HUL, Vedanta, Phoenix Mills and more

Track midday stock movers like HCL Tech, Tata Steel, Mankind Pharma, and Vedanta; review key market catalysts and analyst insights…

July 9, 2025 14:05 IST

Empagliflozin, Empagliflozin generics, Empagliflozin Mankind Pharma, Rajeev Juneja, Glenmark Pharma, Alkem Labs, healthcare news, pharma news,

Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja

On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…

March 12, 2025 13:56 IST

Boehringer Ingelheim, Boehringer Ingelheim India, Boehringer Ingelheim diabetes, Empagliflozin, Empagliflozin in India, patent loss, healthcare news pharma news,

Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India?

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.

March 11, 2025 10:51 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure…

January 23, 2025 19:39 IST

Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore

During the quarter, we have launched 1 new product in US taking the total launched products to 42.

November 5, 2024 17:23 IST

Mankind Pharma acquires BSV to expand its portfolio in women’s health and fertility drug market

According to the company’s statement, Mankind Pharma may consider to retire, a portion of the debt through a potential equity…

October 24, 2024 11:34 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast across categories such…

October 1, 2024 13:57 IST

Mankind Pharma, Mankind Pharma condom, Mankind Pharma owners, Mankind Pharma revneue, Juneja, Juneja brothers, Juneja net worth, Mankind Pharma companies, condom brands in india, lifestyle

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company

Mankind Pharma was founded in 1995 by Ramesh Juneja and his younger brother Rajeev Juneja, marking the beginning of a…

Updated: September 9, 2024 10:27 IST

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India

Mankind Pharma announces entry into topical analgesic market, launches Nimulid Strong

Nimulid Strong will be available in both gel and spray variants, offering consumers flexibility in application, the company stated.

September 2, 2024 17:24 IST

Mankind Pharma, Mankind Pharma Q1 results, quarter earnings, profit, revenue, exports, domestic business, Pharmaceutical industry

Mankind Pharma Q1 Results: Profit rises by 10.2% to Rs 536.49 crore, revenue at Rs 2,893.42 crore

Mankind Pharma recorded revenue from operations at Rs 2,893.42 crore, up 12.2 per cent as against Rs 2,578.62 crore during…

July 31, 2024 15:58 IST

Mankind Pharma, BSV, Mankind Pharma acquisition, BSV news, healthcare news, pharma news,

Mankind Pharma to acquire 100 percent stake in BSV; Plans to expand high entry barrier portfolio

BSV reported revenues of INR 1,723 crore in FY24, delivering robust 20% y-o-y growth with adjusted EBITDA Margins of 28%.…

July 26, 2024 10:48 IST

Mankind Pharma, Q3, top news, latest news, business news,

Mankind Pharma to sell its OTC business on slump sale basis

Some of the key OTC products by Mankind Pharma include the anti-inflammatory and anti-bacterial product AcneStar, the HealthOk multivitamin tablets,…

April 3, 2024 12:59 IST

ChrysCapital pares 2.9 per cent stake in Mankind Pharma for Rs 2,469 crore

According to the bulk deal data available on the NSE, Beige Ltd offloaded more than 1.16 crore shares, amounting to…

March 26, 2024 21:25 IST

Mankind Pharma beats Q3 profit estimates on strong demand

Mankind Pharma, one of India’s leading condom makers, posted a bigger-than-expected rise in third-quarter profit on Wednesday.

January 31, 2024 19:10 IST

Related News

Watchlist 2026: 3 super investor stocks trading at a 40%+ discount,

Damani, Jhunjhunwala & Nemish Shah: 3 ‘deep value’ picks down 40-80%

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

India's maritime MRO revolution: Aatmanirbhar Bharat's next frontier for shipping giants. (Image Source: Mazagondock)

Stop chasing shipbuilding. The real story is ship repair: 3 stocks to watch

Kalamkaval continues its powerful run, collects Rs 54 crore worldwide on Day 6

Life12 min ago

Mammootty’s action crime thriller Kalamkaval released on December 5th 2025 and has already become the fastest of his movies to cross Rs 50 crores worldwide, earning praise for its direction, cinematography, and performances. Directed by Jitin K Jose, the film has earned Rs 24 crores in just 6 days and has a budget of Rs 25 crores.

View all shorts